Treatment of Medication-related osteonecrosis of the jaw: a clinical examinatio
Recruiting
- Conditions
- M87.18
- Registration Number
- DRKS00009411
- Lead Sponsor
- Klinik für Mund-, Kiefer- und Gesichtschirurgie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Patients of the department of oral- and maxillofacial surgery who have been diagnosed with MRONJ, according to the definition of AAOMS, and therefore were treated surgically.
Exclusion Criteria
Patients with a history of radiation to the jaws or obvious metastatic disease to the jaws
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of patients with recurrent MRONJ after treatment.
- Secondary Outcome Measures
Name Time Method Effect of given antiresorptive agent - Bisphosphonates, Denosumab, Bisphosphonates and Denosumab - on:<br>- likeliness of development of recurrent MRONJ<br>- clinical stage of present MRONJ<br>- post-therapeutic course